Skip to main content

Combining Site Specificity and Idiotypy

A Study of Antidigoxin and Antiarsonate Antibodies

  • Chapter
The Biology of Idiotypes

Abstract

We are now rather close to understanding the mechanisms whereby antibody combining site diversity is generated. As this story has unfolded over the past several years, a number of unique genetic mechanisms have been uncovered and many of the issues that fueled controversy among laboratories have been resolved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brack, C., Hirama, M., Lenhard-Schuller, R., and Tonegawa, S., 1978, A complete immunoglobulin gene is created by somatic recombination, Cell 15:1–14.

    Article  PubMed  CAS  Google Scholar 

  2. Sakano, H., Kurosawa, Y., Weigert, M., and Tonegawa, S., 1981, Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes, Nature 290:562–565.

    Article  PubMed  CAS  Google Scholar 

  3. Seidman, J. G., Leder, A., Nau, M., Norman, B., and Leder, P., 1978, Antibody diversity: The structure of cloned immunoglobulin genes suggests a mechanism for generating new sequences, Science 202:11–17.

    Article  PubMed  CAS  Google Scholar 

  4. Seidman, J. G., Max, E. E., and Leder, P., 1979, A kappa-immunoglobulin gene is formed by site-specific recombination without further somatic mutation, Nature 280:370–375.

    Article  PubMed  CAS  Google Scholar 

  5. Early, P., Huang, H., Davis, M., Calame, K., and Hood, L., 1980, An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D, and JH, Cell 19:981–992.

    Article  PubMed  CAS  Google Scholar 

  6. Weigert, M., Gatmaitan, L., Loh, E., Schilling, J., and Hood, L., 1978, Rearrangement of genetic information may produce immunoglobulin diversity, Nature 276:785–790.

    Article  PubMed  CAS  Google Scholar 

  7. Tonegawa, S., 1983, Somatic generation of antibody diversity, Nature 302:575–581.

    Article  PubMed  CAS  Google Scholar 

  8. Gearhart, P. J., 1983, Effect of somatic mutation on antibody affinity, Ann. N.Y. Acad. Sci. 418:171–176.

    Article  PubMed  CAS  Google Scholar 

  9. Clarke, S. H., Claflin, J. L., and Rudikoff, S., 1982, Polymorphisms in immunoglobulin heavy chains suggesting gene conversion,Proc. Natl. Acad. Sci. USA 79:3280–3284.

    Article  PubMed  CAS  Google Scholar 

  10. Hochman, J., Inbar, D., and Givol, D., 1976, An active antibody fragment (Fv) composed of the variable portions of heavy and light chains, Biochemistry 12:1130–1135.

    Article  Google Scholar 

  11. Marquart, M., Deisenhofer, J., Huber, R., and Palm, W., 1980, Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution, J. Mol. Biol. 141:369–391.

    Article  PubMed  CAS  Google Scholar 

  12. Segal, D. M., Padlan, E. A., Cohen, G. H., Rudikoff, S., Potter, M., and Davies, D. R., 1974, The three- dimensional structure of phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site, Proc. Natl. Acad. Sci. USA 71:4298–4302.

    Article  PubMed  CAS  Google Scholar 

  13. Saul, F. A., Amzel, L. M., and Poljak, R. J., 1978, Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin New at 2.0 A resolution, J. Biol. Chem. 253:585–595.

    PubMed  CAS  Google Scholar 

  14. Novotny, J., Bruccoleri, R., Newell, J., Murphy, D., Haber, E., and Karplus, M., 1983, Molecular anatomy of the antibody combining site, J. Biol. Chem. 258:14433–14437.

    PubMed  CAS  Google Scholar 

  15. Kabat, E. A., 1966, The nature of an antigenic determinant, J. Immunol. 97:1–11.

    PubMed  CAS  Google Scholar 

  16. Go, K., Kartha, G., and Chen, J. P., 1980, Structure of digoxin, Acta Crystallogr. Sect. B 36:1811–1819.

    Article  Google Scholar 

  17. Fieser, L. F., and Fieser, M., 1959,Steroids, Reinhold, New York, p. 727.

    Google Scholar 

  18. Smith, T. W., Lloyd, B. L., Spicer, N., and Haber, E., 1979, Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon, Clin. Exp. Immunol. 36:384–396.

    PubMed  CAS  Google Scholar 

  19. Curd, J., Smith, T. W., Jaton, J. C., and Haber, E., 1971, The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin, Proc. Natl. Acad. Sci. USA 68:2401–2406.

    Article  PubMed  CAS  Google Scholar 

  20. Smith, T. W., Butler, V. P., Jr., Haber, E., Fozzard, H., Marcus, F. I., Bremner, W. F., Schulman, I. C., and Phillips, A., 1982, Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: Experience in 26 cases, N. Engl. J. Med. 307:1357–1362.

    Article  PubMed  CAS  Google Scholar 

  21. Aeberhard, P., Butler, V. P., Smith, T. W., Haber, E., Tse Eng, D., Brau, J., Chalom, A., Glatt, B., Thebaut, J. F., Delangenhagen, B., and Morin, B., 1980, Le traitement d’une intoxication digitalique massive (20 mg de digitoxine) par les anticorps anti-digoxine fractionnes (Fab), Arch. Mai. Coeur Vaiss. 73:1471–1478.

    CAS  Google Scholar 

  22. Bismuth, C., Gaultier, M., Conso, F., and Efthymiou, M. L., 1973, Hyperkalemia in acute digitalis poisoning: Prognostic significance and therapeutic implications, Clin. Toxicol. 6:153–162.

    Article  PubMed  CAS  Google Scholar 

  23. Margolies, M. N., Mudgett-Hunter, M., Smith, T. W., Novotny, J., and Haber, E., 1981, Monoclonal antibodies to the cardiac glycoside digoxin, in: Monoclonal Antibodies and T Cell Hybridomas (G. Ham- merling, U. Hammerling, and J. F. Kearney, eds.), Elsevier/North-Holland, Amsterdam, pp. 367–374.

    Google Scholar 

  24. Lechat, P., Mudgett-Hunter, M., Margolies, M. N., Haber, E., and Smith, T. W., 1984, Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments, f. Phys. Exp. Ther. (in press).

    Google Scholar 

  25. Mudgett-Hunter, M., Margolies, M. N., Ju, A., and Haber, E., 1982, High-affinity monoclonal antibodies to the cardiac glycoside digoxin, J. Immunol. 129:1165–1172.

    Google Scholar 

  26. Ochs, H. R., and Smith, T. W., 1977, Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments,J. Clin. Invest. 60:1303–1313.

    Article  PubMed  CAS  Google Scholar 

  27. Smith, T. W., Butler, V. P., and Haber, E., 1970, Characterization of antibodies of high affinity and specificity to the digitalis glycoside digoxin, Biochemistry 9:331–337.

    Article  PubMed  CAS  Google Scholar 

  28. Sigal, N. H., Gearhart, P. J., and Klinman, N. R., 1975, The frequency of phosphorylcholine-specific B cells in conventional and germ free Balb/C mice, J. Immunol. 114:1354–1358.

    PubMed  CAS  Google Scholar 

  29. Sigal, N., 1977, The frequency of/?-azophenylarsonate and dimethylamino-propthalene sulfonyl-specific B cells in neonatal and adult Balb/C mice, J. Immunol. 119:1129–1133.

    PubMed  CAS  Google Scholar 

  30. Kohler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256:494–497.

    Article  Google Scholar 

  31. Shulman, M., Wilde, C. D., and Kohler, G., 1978, A better cell line for making hybridomas secreting specific antibodies, Nature 276:269–270.

    Article  PubMed  CAS  Google Scholar 

  32. Klinman, N. R., Pickard, A. R., Sigal, N. H., Gearhart, P. J., Metcalf, E. S., and Pierce, S. K., 1976, Assessing B cell diversification by antigen receptor and precursor cell analysis,Ann. Immunol. (Paris) 127C:489–502.

    Google Scholar 

  33. Smith, T. W., 1972, Ouabain specific antibodies and immunochemical properties and reversal of Na-K- ATPase inhibition, J. Clin. Invest. 51:1583–1593.

    Article  PubMed  CAS  Google Scholar 

  34. Brauer, A. W., Margolies, M. N., and Haber, E., 1975, The application of 0.1 M Quadrol to the micro- sequence of proteins and the sequence of tryptic peptides, Biochemistry 14:3029–3035.

    Article  PubMed  CAS  Google Scholar 

  35. Novotny, J., and Margolies, M. N., 1983, Amino acid sequence of light chain variable region from a mouse anti-digoxin hybridoma antibody, Biochemistry 22:1153–1158.

    Article  PubMed  CAS  Google Scholar 

  36. Margolies, M. N., and Brauer, A. W., 1978, Protein microsequencing using high pressure liquid chromatography of phenylthiohydantoin amino acids,J. Chromatogr. 148:429–439.

    Article  CAS  Google Scholar 

  37. Margolies, M. N., Brauer, A. W., Oman, C. L., Klapper, D. G., and Horn, M. J., 1982, Improved automatic conversion for use with a liquid-phase sequencer, in: Proceedings of IVth International Conference on Methods in Protein Sequence Analysis (M. Elzinga, ed.), Humana Press, Clifton, N.J., pp. 189–203.

    Chapter  Google Scholar 

  38. Clarke, S. H., Claflin, J. L., Potter, M., and Rudikoff, S., 1982, Polymorphisms in anti-phosphocholine antibodies reflecting evolution of immunoglobulin gene families, J. Exp. Med. 157:98–113.

    Article  Google Scholar 

  39. Rose, D. R., Seaton, B. A., Petsko, G. A., Novotny, J., Margolies, M. N., Locke, E., and Haber, E., 1983, Crystallization of the Fab fragment of a monoclonal anti-digoxin antibody and its complex with digoxin, J. Mol. Biol. 164:203–206.

    Article  Google Scholar 

  40. Kuettner, M. G., Wang, A. L., and Nisonoff, A., 1972, Quantitative investigations of idiotypic antibodies. VI. Idiotypic specificity as a potential genetic marker for the variable regions of mouse immunoglobulin polypeptide chains, J. Exp. Med. 135:579–595.

    Article  PubMed  CAS  Google Scholar 

  41. Pawlak, L. L., Hart, D. A., and Nisonoff, A., 1973, Requirements for prolonged suppression of an idiotypic specificity in adult mice, J. Exp. Med. 137:1442–1458.

    Article  PubMed  CAS  Google Scholar 

  42. Jerne, N. K., 1974, Towards a network theory of the immune system, Ann. Immunol. (Inst. Pasteur) 125C:373–389.

    CAS  Google Scholar 

  43. Capra, J. D., and Nisonoff, A., 1979, Structural studies on induced antibodies with defined idiotypic specificities. VII. The complete amino acid sequence of the heavy chain variable region of anti-jfr-azophenylar- sonate antibodies from A/J mice bearing a cross-reactive idiotype, J. Immunol. 123:279–284.

    PubMed  CAS  Google Scholar 

  44. Marshak-Rothstein, A., Siekevitz, M., Margolies, M. N., Mudgett-Hunter, M., and Gefter, M. L., 1980, Hybridoma proteins expressing the predominant idiotype of the antiphenylarsonate response of the A/J mouse, Proc. Natl. Acad. Sci. USA 77:1120–1124.

    Article  PubMed  CAS  Google Scholar 

  45. Marshak-Rothstein, A., Margolies, M. N., Riblet, R., and Gefter, M. L., 1981, Specificity of idiotype suppression in the A/J anti-azophenylarsonate system, in: Immunoglobulin Idiotypes (C. Janeway, E. E. Sercarz, and H. Wigzell, eds.), Academic Press, New York, pp. 739–749.

    Google Scholar 

  46. Rothstein, T. L., Margolies, M. N., Gefter, M. L., and Marshak-Rothstein, A., 1983, Fine specificity of idiotype suppression in the A/J anti-azophenylarsonate response,J. Exp. Med. 157:795–800.

    Article  PubMed  CAS  Google Scholar 

  47. Marshak-Rothstein, A., Benedetto, J. D., Kirsch, R. L., and Gefter, M. L., 1980, Unique determinants associated with hybridoma proteins expressing a cross-reactive idiotype: Frequency among individual immune sera, J. Immunol. 125:1987–1992.

    PubMed  CAS  Google Scholar 

  48. Nelles, M. J., Gill-Pazaris, L. A., and Nisonoff, A., 1981, Monoclonal anti-idiotypic antibodies reactive with a highly conserved determinant on A/J serum anti-p-azophenylarsonate antibodies, J. Exp. Med. 154:1752–1763.

    Article  PubMed  CAS  Google Scholar 

  49. Estess, P., Nisonoff, A., and Capra, J. D., 1979, Structural studies on induced antibodies with defined idiotypic specificities. VIII. NH2-terminal amino acid sequence analysis of the heavy and light chain variable regions of monoclonal anti-/?-azophenylarsonate antibodies from A/J mice differing with respect to a cross-reactive idiotype, Mol. Immunol. 16:1111–1116.

    Article  PubMed  CAS  Google Scholar 

  50. Estess, P., Lamoyi, E., Nisonoff, A., and Capra, J. D., 1980, Structural studies on induced antibodies with defined idiotype specificities. IX. Framework differences in the heavy- and light-chain-variable regions of monoclonal anti-/?-azophenylarsonate antibodies from A/J mice differing with respect to a cross-reactive idiotype, J. Exp. Med. 151:863–875.

    Article  PubMed  CAS  Google Scholar 

  51. Margolies, M. N., Marshak-Rothstein, A., and Gefter, M. L., 1981, Structural diversity among anti-p- azophenylarsonate monoclonal antibodies from A/J mice: Comparison of Id- and Id+ sequences, Mol. Immunol. 18:1065–1077.

    Article  PubMed  CAS  Google Scholar 

  52. Siegelman, M., and Capra, J. D., 1981, Complete amino acid sequence of light chain variable regions derived from five monoclonal anti-jfr-azophenylarsonate antibodies differing with respect to a cross-reactive idiotype, Proc. Natl. Acad. Sci. USA 78:7679–7683.

    Article  PubMed  CAS  Google Scholar 

  53. Ball, R. K., Chang, J. Y., Alkan, S. S., and Braun, D. G., 1983, The complete amino acid sequence of the light chain variable region of two monoclonal anti-jfr-azobenzene-arsonate antibodies bearing the cross- reactive idiotype, Mol. Immunol. 20:197–201.

    Article  PubMed  CAS  Google Scholar 

  54. Siekevitz, M., Gefter, M. L., Brodeur, P., Riblet, R., and Marshak-Rothstein, A., 1982, The genetic basis of antibody production: The dominant anti-arsonate idiotype response of the strain A mouse, Eur. J. Immunol. 12:1023–1032.

    Article  PubMed  CAS  Google Scholar 

  55. Siekevitz, M., Huang, S. Y., and Gefter, M. L., 1983, The genetic basis of antibody production: One variable region heavy chain gene encodes all molecules bearing the dominant anti-arsonate idiotype in the strain A mouse, Eur. J. Immunol. 13:123–132.

    Article  PubMed  CAS  Google Scholar 

  56. Marshak-Rothstein, A., Margolies, M. N., Benedetto, J. D., and Gefter, M. L., 1981, Two structurally distinct and independently regulated families associated with the A/J response to azophenylarsonate, Eur. J. Immunol. 11:565–572.

    Article  PubMed  CAS  Google Scholar 

  57. Milner, E. C. B., and Capra, J. D., 1982, VH families in the antibody response to jfr-azophenylarsonate: Correlation between serology and amino acid sequence,J. Immunol. 129:193–199.

    PubMed  CAS  Google Scholar 

  58. Kurosawa, Y., and Tonegawa, S., 1982, Organization, structure and assembly of immunoglobulin heavy chain diversity DNA segments, J. Exp. Med. 155:201–218.

    Article  PubMed  CAS  Google Scholar 

  59. Margolies, M. N., Juszczak, E. C., Near, R., Marshak-Rothstein, A., Rothstein, T. L., Sato, V. L., Siekevitz, M., Smith, J. A., Wysocki, L. J., and Gefter, M. L., 1983, Structural correlates of idiotypy in the arsonate system, Ann. N.Y. Acad. Sci. 418:48–64.

    Article  PubMed  CAS  Google Scholar 

  60. Capra, J. D., Slaughter, C., Milner, E. C. B., Estess, P., and Tucker, P. W., 1982, The cross-reactive idiotype of A strain mice, serological and structural analysis, Immunol. Today 3:332–339.

    Article  CAS  Google Scholar 

  61. Wysocki, L. J., and Sato, V. L., 1981, The strain A anti-/?-azophenylarsonate major cross-reactive idiotypic family includes members with no reactivity towards -azophenylarsonate, Eur. J. Immunol. 11:832–839.

    Article  PubMed  CAS  Google Scholar 

  62. Margolies, M. N., Wysocki, L. J., and Sato, V. L., 1983, Immunoglobulin idiotype and anti-anti-idiotype utilize the same variable region genes irrespective of antigen specificity, J. Immunol. 130:515–517.

    PubMed  CAS  Google Scholar 

  63. Gefter, M. L., Margolies, M. N., Near, R., and Wysocki, L. J., 1984, Analysis of the anti-azo-benzene- arsonate response at the molecular level, Ann. Inst. Pasteur 135:17–30.

    Google Scholar 

  64. Milner, E. C. B., and Capra, J. D., 1983, Structural analysis of monoclonal anti-arsonate antibodies: Idiotypic specificities are determined by the heavy chain,Mol. Immunol. 20:39–46.

    Article  PubMed  CAS  Google Scholar 

  65. Cannon, L. E., and Woodland, R. T., 1983, Rapid and sensitive procedure for assigning idiotype determinants to heavy or light chains: Application to idiotype associated with the major cross-reactive idiotype of A/J antiphenylarsonate antibody, Molec. Immunol. 20:1283–1288.

    Article  CAS  Google Scholar 

  66. Sakano, H., Maki, R., Kurosawa, Y., Roeder, W., and Tonegawa, S., 1980, Two types of somatic recombination necessary for the generation of complete immunogloublin heavy-chain genes, Nature 286:676–683.

    Article  PubMed  CAS  Google Scholar 

  67. Cook, W. D., Rudikoff, S., Giusti, A., and Scharff, M. D., 1982, Somatic mutation in a cultured mouse myeloma cell affects antigen binding, Proc. Natl. Acad. Sci. USA 79:1240–1244.

    Article  PubMed  CAS  Google Scholar 

  68. Rudikoff, S., Giusti, A. M., Cook, W. D., and Scharff, M. D., 1982, Single amino acid substitution altering antigen-binding specificity,Proc. Natl. Acad. Sci. USA 79:1979–1983.

    Article  PubMed  CAS  Google Scholar 

  69. Near, R. I., Juszczak, E. C., Huang, S. Y., Sicari, S. A., Margolies, M. N., and Gefter, M. L., 1984, Expression and rearrangement of homologous immunoglobulin VH genes in two mouse strains, Proc. Natl. Acad. Sci. USA 81:2167–2171.

    Article  PubMed  CAS  Google Scholar 

  70. Gill-Pazaris, L. A., Brown, A. R., and Nisonoff, A., 1979, The nature of idiotypes associated with anti-p- azophenylarsonate antibodies in A/J mice, Ann. Immunol. (Inst. Pasteur) 130C: 199–213.

    CAS  Google Scholar 

  71. Brown, A. R., and Nisonoff, A., 1981, An intrastrain cross-reactive idiotype associated with anti-jfr-azo- phenylarsonate antibodies of Balb/C mice, J. Immunol. 126:1263–1267.

    PubMed  CAS  Google Scholar 

  72. Brown, A. R., Lamoyi, E., and Nisonoff, A., 1981, Relationship of idiotypes of the anti-/?-azophenylar- sonate antibodies of A/J and Balb/C mice, J. Immunol. 126:1268–1273.

    PubMed  CAS  Google Scholar 

  73. Brown, A. R., 1983, Idiotypic heterogeneity of the cross-reactive idiotype associated with the anti-/?-azo- phenylarsonate antibodies of Balb/C mice,J. Immunol. 131:423–428.

    PubMed  CAS  Google Scholar 

  74. Juszczak, E. C., Near, R., and Margolies, M. N., 1984, in preparation.

    Google Scholar 

  75. Juszczak, E. C., and Margolies, M. N., 1983, Amino acid sequence of the heavy chain variable region from the A/J mouse anti-arsonate monoclonal antibody 36–60 bearing a minor idiotype, Biochemistry 22:4291- 4296.

    Article  PubMed  CAS  Google Scholar 

  76. Gearhart, P. J., Johnson, N. D., Douglas, R., and Hood, L., 1981, IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts, Nature 291:29–34.

    Article  PubMed  CAS  Google Scholar 

  77. Rothstein, T. L., and Gefter, M. L., 1983, Affinity analysis of idiotype-positive and idiotype-negative arsonate-binding hybridoma proteins and Ars-immune sera,Mol. Immunol. 20:161–168.

    Article  PubMed  CAS  Google Scholar 

  78. Lewis, G. K., Kaymakcalan, Z., Yao, J., and Goodman, J. W., 1983, Idiotype connectance between anti- arsonate and anti-dinitrophenyl responses in Balb/C mice, Ann. N.Y. Acad. Sci. 418:282–289.

    Article  PubMed  CAS  Google Scholar 

  79. Frederick, W. A., and Baltimore, D., 1982, Joining of immunoglobulin heavy chain gene segments: Implications from a chromosome with evidence of 3 D-JH fusions, Proc. Natl. Acad. Sci. USA 79:4118–4122.

    Article  Google Scholar 

  80. Oi, V. T., Morrison, S. L., Herzenberg, L. A., and Berg, P., 1983, Immunoglobulin gene expression in transformed lymphoid cells, Proc. Natl. Acad. Sci. USA 89:825–829.

    Article  Google Scholar 

  81. IUPAC-IUB Commission on Biochemical Nomenclature, 1968, J. Biol. Chem. 243:3557–3559.

    Google Scholar 

  82. Rabat, E. A., Wu, T. T., and Bilofsky, H., 1979, Sequences of immunoglobulin chains: Tabulation and analyses of amino acid sequences of precursors, V-regions, C-regions, J-chains and BP-microglobulins, NIH Publication 80–2008.

    Google Scholar 

  83. Siegelman, M., Slaughter, C., McCumber, L., Estess, P., and Capra, J. D., 1981, Primary structural studies of monoclonal A/J anti-arsonate antibodies differing with respect to a cross-reactive idiotype, in: Immunoglobulin Idiotypes (C. Janeway, E. E. Sercarz, and H. Wigzell, eds.), Academic Press, New York, pp. 135–158.

    Google Scholar 

  84. Sims, J., Rabbitts, T. H., Estess, P., Slaugher, C., Tucker, P. W., and Capra, J. D., 1982, Somatic mutation in genes for the variable portions of the immunoglobulin heavy chain, Science 216:309–310.

    Article  PubMed  CAS  Google Scholar 

  85. Alkan, S. S., Knecht, R., and Braun, D. G., 1980, The cross-reactive idiotype of anti-4-azobenzene-arsonate hybridoma-derived antibodies in A/J mice constitutes multiple heavy chains, Z. Physiol. Chem. 361:191–195

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Haber, E., Margolies, M.N. (1984). Combining Site Specificity and Idiotypy. In: Greene, M.I., Nisonoff, A. (eds) The Biology of Idiotypes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4739-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4739-2_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4741-5

  • Online ISBN: 978-1-4684-4739-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics